Chemistry: analytical and immunological testing – Immunochemical pregnancy determination
Patent
1994-06-29
1996-05-14
Parr, Margaret
Chemistry: analytical and immunological testing
Immunochemical pregnancy determination
435 71, 435 724, 435 792, 436518, 436536, 436 65, 436 86, 436814, G01N 3368, G01N 33543, G01N 3353
Patent
active
055167020
ABSTRACT:
The present invention provides an early, biochemical indication of increased risk of impending preterm delivery. The method comprises obtaining a cervicovaginal secretion sample from a pregnant patient after week 12 of gestation and determining the level of a local inflammatory product protein in the sample. The presence of an elevated level of the selected protein in the sample indicates an increased risk of delivery. The test is a screening assay that can detect women at risk of imminent delivery, as early as two to three weeks prior to delivery.
REFERENCES:
patent: 5096830 (1992-03-01), Senyei et al.
Hunt, 1990. Current topic The role of macrophages in the uterine response to pregnancy. Placenta 11:467-475.
Lockwood et al, 1991. Fetal fibronection in cervical and vaginal secretions as a predictor of preterm delivery. NE J Med 325:669-674.
Santhanam et al, 1991. Cytokines in normal and abnormal parturition: Elevated amniotic fluid IL-6 levels . . . Cytokine 3:155-163.
Mohamed, et al., Chemical Abst., vol. 102, No. 202100t, 1985.
Seifert, et al., Chemical Abst., vol. 96, No. 136771s, 1982.
Grudzinskas et al., Reprod. Perinat. Med., 1985, pp. 153-156.
McGregor, et al., Am. J. Obstet, Gynecol., vol. 154, No. 1, 1986, pp. 109-114.
Kanayama, et al., Asia-Oceania J. Obstet, Gynecol, vol. 14, No. 3, 1988, pp. 389-397.
Teng et al-Chem. Abst. vol. 112 (1990) p. 73417g.
Mohamed et al-Chem. Abst. vol. 104 (1986) p. 4137p.
Casal David C.
Senyei Andrew E.
Adeza Biomedical Corporation
Grun James L.
Haliday Emily M.
Parr Margaret
Terlizzi Laura
LandOfFree
Screening method for identifying women at increased risk for imm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for identifying women at increased risk for imm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for identifying women at increased risk for imm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895305